Neuroscience institute Cavalieri Ottolenghi

The main goal of NICO research center is to study the fundamental biological mechanisms of nervous system function, whose knowledge is essential for the development of innovative therapeutic approaches for neurodegenerative diseases and psychiatric disorders.

NICO is an interdepartmental institute of Turin University devoted to Neuroscience. We focus in developing a multidisciplinary approach that combines the skills and expertise of our faculty, with the goal of integrating basic research and its clinical applications.

70

RESEARCHERS

30

YEARS
average age

20

PROFESSORS

60%

WOMEN
researchers

50+

SCIENTIFIC PUBLICATIONS
per year

Pharmacological c-Jun NH(2)-Terminal Kinase (JNK) Pathway Inhibition Reduces Severity of Spinal Muscular Atrophy Disease in Mice

Frontiers in Molecular Neuroscience , September 2018
R Schellino, M Boido, T Borsello, A Vercelli

24 october 2018

Multiple origins and modularity in the spatiotemporal emergence of cerebellar astrocyte heterogeneity

Plos Biology , 27 September 2018
V Cerrato, E Parmigiani, M Figueres-Oñate, M Betizeau, J Aprato, I Nanavaty, P Berchialla, F Luzzati, C de’Sperati, L Lopez-Mascaraque, A Buffo

11 october 2018

The multifaceted interactions between sex and brain. A meeting in honor of Luciano Martini

Our member prof. Giancarlo Panzica (University of Turin) will attend the meeting organized by the  Accademia Nazionale dei Lincei  with a lecture on   " Environmental modulation of neural circuits and behavior " .

28 November 2018

Events & Meetings

16 february 2019

Torino - 10th International Meeting STEROIDS and NERVOUS SYSTEM

Since 2001, this meeting represented an important event for basic and clinical researchers working on this emerging scientific topic. We will address state-of-the-art approaches in the field of steroids and nervous system, including behavior, epigenetics, genomic and non-genomic actions, the vitamin D, neurodegenerative and psychiatric disorders, and the interference among endocrine disruptors and steroid signaling.